adplus-dvertising
News

‎Nigeria requires N2.2trn to eliminate cervical cancer by 2030 – Prof. Adewole

NigeriaPlateau

‎Prof. Isaac Adewole, Chairman of the National Task Force on Cervical Cancer Elimination (NTF-CCE), says Nigeria will require N2.2 trillion to implement comprehensive cervical cancer interventions between 2026 and 2030.

‎By Folasade Akpan

‎Prof. Isaac Adewole, Chairman of the National Task Force on Cervical Cancer Elimination (NTF-CCE), says Nigeria will require N2.2 trillion to implement comprehensive cervical cancer interventions between 2026 and 2030.

‎Adewole, a former Minister of Health, made this known on Tuesday in Abuja during the launch of the Partnership to Eliminate Cervical Cancer in Nigeria (PECCiN), an initiative of the NTF-CCE.

‎The initiative, launched at the State House by the First Lady, Sen. Oluremi Tinubu, aims to accelerate Nigeria’s achievement of the World Health Organisation’s (WHO) 90-70-90 targets for cervical cancer elimination.

‎The News Agency of Nigeria (NAN) reports that PECCiN seeks to catalyse multi-sectoral efforts to prevent, screen, and treat cervical cancer through sustained coordination, resource mobilisation, and scale-up of service delivery.

‎According to Adewole, the interventions are grouped into three categories: primary prevention, secondary prevention, and tertiary treatment.

‎He explained that the Human Papilloma Virus (HPV) vaccination programme will be delivered through fixed sessions at health facilities and outreach-based immunisation campaigns.

‎“The total direct implementation cost over the five years is estimated at N387.52 billion,” he said.

‎“Including administrative and supervisory costs, the total cost of HPV vaccination will amount to N426.28 billion.”

‎He said cervical cancer screening over the same period is estimated to cost N351 billion, targeting 14.4 million women.

‎On tertiary treatment, Adewole noted that nearly 300,000 women will require care for invasive cervical cancer between 2026 and 2030.

‎“The country is projected to spend approximately N1.42 trillion on treatment, with the cost per patient dropping from N8.7 million in 2026 to N4.1 million by 2030,” he added.

‎In spite of other competing priorities, he urged investment in cervical cancer elimination due to its high return on investment.

‎“We seek your commitment and support to implement robust cervical cancer elimination interventions in Nigeria.

‎“This will ensure that every woman is financially protected throughout her life and no eligible adolescent is left behind in HPV vaccination.”